Subspecialties

A retrospective study by the Neuromyelitis Optica Study Group helps physicians better understand the challenging disease

Photoreceptors – and the retina in general – are highly metabolically active. But their maxed-out mitochondria can’t give much more. And when even small metabolic imbalances arise…

Three new pipeline therapies may offer relief to patients with ocular surface disease

Daniel Black discusses his experience with the ZEISS Cataract Suite markerless in the latest episode of In Conversation With…

The unveiling of SPECTRALIS® OCT angiography* is one of the highlights for Heidelberg Engineering in 2016. Its Managing Director Dr. Kester Nahen explains the distinctive features and new possibilities of this technology.

5-year ATOM2 trial data confirms that 0.01% atropine is more effective at slowing myopia progression than 0.1% and 0.5% doses

A specialized imaging technique has revealed two previously unknown structures of the cornea

A new matrix therapy agent may promote corneal healing after epi-off CXL, improving patient comfort and recovery times

Highlights from Laboratoires Théa’s Satellite Education Program, “Ocular Surface: What’s New?” held on October 8, 2015, at the 7th EVER Congress, Nice, France.

What does analysis of the last five years of literature on endophthalmitis tell us about the priorities of the field, and the contributors to it?